DOPA decarboxylase/DDC Recombinant antibody

DOPA decarboxylase/DDC Uni-rAbTM Recombinant Antibody for WB, ELISA
Cat No. 85811-2-RR
Clone No.243125A1

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse

Applications

WB, ELISA

DDC, DOPA decarboxylase, AADC, Aromatic-L-amino-acid decarboxylase, EC:4.1.1.28

Formulation:  PBS and Azide
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive WB detected inSH-SY5Y cells, mouse brain tissue, mouse kidney tissue

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:5000-1:50000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

85811-2-RR targets DOPA decarboxylase/DDC in WB, ELISA applications and shows reactivity with human, mouse samples.

Tested Reactivity human, mouse
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen DOPA decarboxylase/DDC fusion protein Ag0219 Predict reactive species
Full Name dopa decarboxylase (aromatic L-amino acid decarboxylase)
Calculated Molecular Weight 54 kDa
Observed Molecular Weight 48-50 kDa
GenBank Accession NumberBC008366
Gene Symbol DOPA decarboxylase
Gene ID (NCBI) 1644
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
UNIPROT IDP20711
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

DOPA decarboxylase (DDC), also known as aromatic l-amino acid decarboxylase, belongs to the pyridoxal-dependent aminotransferase superfamily. DDC is an enzyme that converts levodopa into dopamine14, the latter being severely depleted in LBD due to the loss of dopaminergic neurons in the substantia nigra (PMID: 3374198, PMID: 28100251). DDC catalyzes the decarboxylation of L-3,4-dihydroxyphenylalanine (DOPA) to dopamine, L-5-hydroxytryptophan to serotonin and L-tryptophan to tryptamine. DDC is the cause of aromatic L-amino-acid decarboxylase deficiency (AADCD). Researches showed that Ddc is only one of the enzymes in the biosynthetic pathways for bioamines and catecholamines.

Protocols

Product Specific Protocols
WB protocol for DOPA decarboxylase/DDC antibody 85811-2-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...